SCHEMBL24469716

SCHEMBL24469716

COC(=O)C(Oc1ccc(OC)cc1)c1ccccc1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
GAA P10253 2/20 0.49
POLB P06746 1/20 0.49
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
PPARA Q07869 5/20 0.44
PPARG P37231 4/20 0.44
BACE1 P56817 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HDAC4 P56524 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HSP90AA1 P07900 2/20 0.41
HSP90AB1 P08238 2/20 0.41
KIF11 P52732 1/20 0.41
CYP3A4 P08684 1/20 0.41
KLK7 P49862 1/20 0.41
CTSK P43235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30585539 1.00 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL30585530 0.89 PPARA (0.49) ALDH1A1GAAPOLBTAS1R3TAS1R1
SCHEMBL26978821 0.89 PPARA (0.49) ALDH1A1GAAPOLBTAS1R3TAS1R1
SCHEMBL31532232 0.86 GAA (0.46) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL24469712 0.86 GAA (0.46) ALDH1A1KDM4EHPGDGAAPOLB
SCHEMBL27275 0.82 KMT2A (0.44) ALDH1A1HPGDGAAPOLBTAS1R3
SCHEMBL24469703 0.80 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGAATAS1R3
SCHEMBL7254510 0.79 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDPOLBPPARA
SCHEMBL24469714 0.78 SCN1A (0.46) ALDH1A1CYP1A2
SCHEMBL31532234 0.78 SCN1A (0.46) ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606549-B2 Anticholinergic agents REZUBIO PHARMACEUTICALS CO., LTD (CN) 2026-04-21 US disclosed
US-20240002372-A1 ANTICHOLINERGIC AGENTS REZUBIO PHARMACEUTICALS CO., LTD (CN) 2024-01-04 US disclosed
CN-116669721-A Anticholinergic agent 宁康瑞珠生物制药(珠海)有限公司 2023-08-29 CN disclosed
WO-2022111500-A1 ANTICHOLINERGIC AGENTS REZUBIO PHARMACEUTICALS CO., LTD (CN) 2022-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002372-A1 ANTICHOLINERGIC AGENTS CHRM3, CHRM2, CHRM1 ALDH1A1 1275/4885KDM4E 4250/4885HPGD 1114/4885
US-12606549-B2 Anticholinergic agents CHRM1, CHRNA1, CHRND ALDH1A1 3137/4885KDM4E 3010/4885HPGD 2214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.